| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 9, 2008
Revised on May 13, 2009
Accepted on May 13, 2009
Regulates Extracellular Matrix and Apoptosis of Vascular Smooth Muscle Cells Through the Activation of Transforming Growth Factor-
1/Smad3
From the Department of Pharmacology (Hyo Jung Kim, M.Y.K., H.J., Hye Jung Kim, J.H.L., K.C.C., H.G.S.), Anatomy (H.J.K., S.S.K.), and Internal Medicine (J.-Y.H.), Gyeongsang Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea; Department of Pharmacology (C.Y.-N.), Kyoto Prefectural University of Medicine, Japan; and Department of Animal Biotechnology (J.-H.K.), Kon-Kuk University, Seoul, Korea.
* To whom correspondence should be addressed. E-mail: hgseo{at}gnu.ac.kr.
Homeostasis of the extracellular matrix and apoptosis of vascular smooth muscle cells (VSMCs) are key components in the regulation of the stability of atherosclerotic plaques. Here, we demonstrate that peroxisome proliferator-activated receptor (PPAR)
regulates extracellular matrix synthesis and degradation through transforming growth factor-
1 and its effector, Smad3. Activation of PPAR
strongly amplified the expression of types I and III collagen, fibronectin, elastin, and TIMP-3 (tissue inhibitor of metalloproteinases 3), but not of TIMP-1, matrix metalloproteinase-2 or -9. The effect of PPAR
on the expression of type III collagen was dually regulated by the direct binding of PPAR
and Smad3 to a direct repeat-1 site and a Smad-binding element, respectively, in the type III collagen gene promoter. The activation of PPAR
attenuated apoptotic cell death in VSMCs induced by oxidized low-density lipoprotein, and similar antiapoptotic effects were observed on treatment of cells with exogenous type I and/or III collagen. Administration of a PPAR
ligand GW501516 to mice also suppressed elastase-induced cell death of aortic VSMCs. These results suggest that PPAR
-induced upregulation of extracellular matrix proteins exerts an antiapoptotic effect, thereby maintaining the stability of atherosclerotic plaques. Specific ligands of PPAR
may aid in the therapeutic intervention of atherosclerosis by improving plaque stability and patient prognosis.
transforming growth factor-
1
vascular smooth muscle cells
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |